The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Nano-palladium is a cellular catalyst for in vivo chemistry
Open accessAbstract
Palladium catalysts have been widely adopted for organic synthesis and diverse industrial applications given their efficacy and safety, yet their biological in vivo use has been limited to date. Here we show that nanoencapsulated palladium is an effective means to target and treat disease through in vivo catalysis. Palladium nanoparticles (Pd-NPs) were created by screening different Pd compounds and then encapsulating bis[tri(2-furyl)phosphine]palladium(II) dichloride in a biocompatible poly(lactic-co-glycolic acid)-b-polyethyleneglycol platform. Using mouse models of cancer, the NPs efficiently accumulated in tumours, where the Pd-NP activated different model prodrugs. Longitudinal studies confirmed that prodrug activation by Pd-NP inhibits tumour growth, extends survival in tumour-bearing mice and mitigates toxicity compared to standard doxorubicin formulations. Thus, here we demonstrate safe and efficacious in vivo catalytic activity of a Pd compound in mammals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Microbial engineering for the production of advanced biofuels
Peralta-Yahya, P. P., Zhang, F., del Cardayre, S. B., & Keasling, J. D. (2012) · Nature · doi:10.1038/nature11478 · Cited by 1,097
Farina, V., & Krishnan, B. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00025a025 · Cited by 1,041
Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
Design of functional metalloproteins
Lu, Y., Yeung, N., Sieracki, N., & Marshall, N. M. (2009) · Nature · doi:10.1038/nature08304 · Cited by 704
Dissecting tumour pathophysiology using intravital microscopy
Jain, R. K., Munn, L. L., & Fukumura, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc778 · Cited by 595
Development of a Syngeneic Mouse Model for Events Related to Ovarian Cancer
Roby, K. F., Taylor, C. C., Sweetwood, J. P., Cheng, Y., Pace, J. L., Tawfik, O., Persons, D. L., Smith, P. G., & Terranova, P. F. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.585 · Cited by 593
Palladium-mediated intracellular chemistry
Yusop, R. M., Unciti-Broceta, A., Johansson, E. M. V., Sánchez-Martín, R. M., & Bradley, M. (2011) · Nature Chemistry · doi:10.1038/nchem.981 · Cited by 531
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Palladium-triggered deprotection chemistry for protein activation in living cells
Li, J., Yu, J., Zhao, J., Wang, J., Zheng, S., Lin, S., Chen, L., Yang, M., Jia, S., Zhang, X., et al. (2014) · Nature Chemistry · doi:10.1038/nchem.1887 · Cited by 463
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9692 · Cited by 441
Self-citationPolymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Biocompatible Copper(I) Catalysts for in Vivo Imaging of Glycans
Soriano del Amo, D., Wang, W., Jiang, H., Besanceney, C., Yan, A. C., Levy, M., Liu, Y., Marlow, F. L., & Wu, P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja106553e · Cited by 390
Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
Kapdi, A. R., & Fairlamb, I. J. S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00063c · Cited by 379
Weiss, J. T., Dawson, J. C., Macleod, K. G., Rybski, W., Fraser, C., Torres-Sánchez, C., Patton, E. E., Bradley, M., Carragher, N. O., & Unciti-Broceta, A. (2014) · Nature Communications · doi:10.1038/ncomms4277 · Cited by 359
Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes
Köhler, V., Wilson, Y. M., Dürrenberger, M., Ghislieri, D., Churakova, E., Quinto, T., Knörr, L., Häussinger, D., Hollmann, F., Turner, N. J., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1498 · Cited by 347
Miller, M. A., Gadde, S., Pfirschke, C., Engblom, C., Sprachman, M. M., Kohler, R. H., Yang, K. S., Laughney, A. M., Wojtkiewicz, G., Kamaly, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6522 · Cited by 347
Self-citationActive targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Huang, B., Abraham, W. D., Zheng, Y., Bustamante López, S. C., Luo, S. S., & Irvine, D. J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5447 · Cited by 312
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Xu, R., Zhang, G., Mai, J., Deng, X., Segura-Ibarra, V., Wu, S., Shen, J., Liu, H., Hu, Z., Chen, L., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3506 · Cited by 280
Li, N., Lim, R. K. V., Edwardraja, S., & Lin, Q. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2066913 · Cited by 266
Palladium-Mediated Cell-Surface Labeling
Spicer, C. D., Triemer, T., & Davis, B. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209352s · Cited by 259
Ling, Y. H., el-Naggar, A. K., Priebe, W., & Perez-Soler, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09073-x · Cited by 213
Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine
Weiss, J. T., Dawson, J. C., Fraser, C., Rybski, W. M., Torres-Sánchez, C., Bradley, M., Patton, E. E., Carragher, N. O., & Unciti‐Broceta, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500531z · Cited by 208
Bergsten, P., Amitai, G., Kehrl, J., Dhariwal, K. R., Klein, H. G., & Levine, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39841-2 · Cited by 199
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Wright, A. A., Cronin, A., Milne, D. E., Bookman, M. A., Burger, R. A., Cohn, D. E., Cristea, M. C., Griggs, J. J., Keating, N. L., Levenback, C. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4776 · Cited by 185
Trachtenberg, J., Bogaards, A., Weersink, R. A., Haider, M. A., Evans, A., McCluskey, S. A., Scherz, A., Gertner, M. R., Yue, C., Appu, S., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.07.036 · Cited by 176
Li, J., Lin, S., Wang, J., Jia, S., Yang, M., Hao, Z., Zhang, X., & Chen, P. R. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402424j · Cited by 172
The Power and Potential of Doxorubicin‐DNA Adducts
Cutts, S. M., Nudelman, A., Rephaeli, A., & Phillips, D. R. (2005) · IUBMB Life · doi:10.1080/15216540500079093 · Cited by 168
Alexander, S., Weigelin, B., Winkler, F., & Friedl, P. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.001 · Cited by 151
Wei, C. S., Davies, G. H. M., Soltani, O., Albrecht, J. W., Gao, Q., Pathirana, C., Hsiao, Y., Tummala, S., & Eastgate, M. D. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201210252 · Cited by 130
Beletsi, A., Panagi, Z., & Avgoustakis, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.024 · Cited by 128
Völker, T., & Meggers, E. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.12.021 · Cited by 120
Suntharalingam, K., Johnstone, T. C., Bruno, P. M., Wei, L., Hemann, M. T., & Lippard, S. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4075375 · Cited by 102
Necroptosis-Inducing Rhenium(V) Oxo Complexes
Suntharalingam, K., Awuah, S. G., Bruno, P. M., Johnstone, T. C., Wang, F., Wei, L., Zheng, Y., Page, J. E., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511978y · Cited by 98
Stechman, M., Ahmad, B. N., Loh, N. Y., Reed, A. J., Stewart, M. E., Wells, S. E., Hough, T., Bentley, L., Cox, R., Brown, S. D. M., et al. (2010) · Laboratory Animals · doi:10.1258/la.2010.009128 · Cited by 80
Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles
Valencia, P. M., Pridgen, E. M., Perea, B., Gadde, S., Sweeney, C. J., Kantoff, P. W., Bander, N. H., Lippard, S. J., Langer, R., Karnik, R., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.134 · Cited by 78
Laughney, A. M., Kim, E., Sprachman, M. M., Miller, M. A., Köhler, R. H., Yang, K. S., Orth, J. D., Mitchison, T. J., & Weissleder, R. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009318 · Cited by 77
Self-citationWeiss, J. T., Carragher, N. O., & Unciti‐Broceta, A. (2015) · Scientific Reports · doi:10.1038/srep09329 · Cited by 73
Single cell resolution in vivo imaging of DNA damage following PARP inhibition
Yang, K. S., Köhler, R. H., Landon, M., Giedt, R. J., & Weissleder, R. (2015) · Scientific Reports · doi:10.1038/srep10129 · Cited by 61
Self-citationVanhoefer, U. J., Cao, S., Minderman, H., Tóth, K., Skenderis, B. S., Slovak, M. L., & Rustum, Y. M. (1996) · PubMed · Cited by 59
Platinum Compounds for High‐Resolution In Vivo Cancer Imaging
Miller, M. A., Askevold, B., Yang, K. S., Köhler, R. H., & Weissleder, R. (2014) · ChemMedChem · doi:10.1002/cmdc.201300502 · Cited by 57
Self-citationHeavy metal analysis using a Heck-catalyzed cyclization to create coumarin
Wu, Q., & Anslyn, E. V. (2005) · Journal of Materials Chemistry · doi:10.1039/b502199p · Cited by 35
Farah, H. S., Al, A. A., & Shehab, G. M. G. (2012) · Cited by 14
Cited by
Scinto, S. L., Bilodeau, D. A., Hincapie, R., Lee, W., Nguyen, S. S., Xu, M., am Ende, C. W., Finn, M. G., Lang, K., Lin, Q., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00028-z · Cited by 592
Imaging of anticancer drug action in single cells
Miller, M. A., & Weissleder, R. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.41 · Cited by 92
Self-citationImproving nanotherapy delivery and action through image-guided systems pharmacology
Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Theranostics · doi:10.7150/thno.37215 · Cited by 60
Self-citation
Metadata
- Authors
- Miller, M. A., Askevold, B., Mikula, H., Kohler, R. H., Pirovich, D., & Weissleder, R.
- Venue
- Nature Communications
- Published
- 2017-07-12
- Volume
- 8
- Issue
- 1
- Pages
- 15906-15906
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2734381642
- Cited by
- 288
- References
- 51
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
